Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-50,000
Closed -$595K – 3678
2018
Q4
$595K Buy
+50,000
New +$713K ﹤0.01% 2996

Other funds holding EOLS

David Shaw's EOLS Position: Q3 2026 in Review

David Shaw increased its Evolus (EOLS) stake by 0.61% in Q3 2026, buying an estimated $15.4K and bringing the position to 338,959 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

David Shaw first reported a position in EOLS in Q3 2018 and has held it in 24 quarters since. The position peaked at $15.7M in Q3 2024. 170 funds tracked by Wall St. Rank hold EOLS as of Q3 2026.

  • David Shaw held 338,959 shares of Evolus worth $2.71M as of Q3 2026.
  • David Shaw bought 2,058 Evolus shares in Q3 2026, an estimated $15.4K.
  • Evolus made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2987 holding.
  • David Shaw first reported a position in Evolus in Q3 2018 and has held it in 24 quarters since.
  • David Shaw's Evolus position peaked at $15.7M in Q3 2024.
  • 170 funds tracked by Wall St. Rank held Evolus as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.